Outlook Therapeutics, Inc. (OTLK) › Shareholders' EquityOutlook Therapeutics, Inc. (OTLK) — Shareholders' EquityAnnual figures by period end, from SEC filings.2015-09-30: -$54.22M2016-09-30: -$5.17M2017-09-30: -$33.65M2018-09-30: -$25.54M2019-09-30: -$16.13M2020-09-30: $2.83M2021-09-30: $4.61M2022-09-30: $8.74M2023-09-30: -$14.44M2024-09-30: -$73.08M2025-09-30: -$32.19M-$32.19M2015-09-30Shareholders' Equity (USD)2025-09-30Period endedShareholders' EquityChange YoYSource filing2025-09-30-$32.19M—2025-12-19Balance as of period end2024-09-30-$73.08M—2025-12-19Balance as of period end2023-09-30-$14.44M-265.3%2025-12-19Balance as of period end2022-09-30$8.74M+89.6%2024-12-27Balance as of period end2021-09-30$4.61M+63.0%2023-12-22Balance as of period end2020-09-30$2.83M—2022-12-29Balance as of period end2019-09-30-$16.13M—2021-12-23Balance as of period end2018-09-30-$25.54M—2020-12-23Balance as of period end2017-09-30-$33.65M—2018-12-18Balance as of period end2016-09-30-$5.17M—2017-12-29Balance as of period end2015-09-30-$54.22M—2016-12-29Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)